BW
ABBV icon

Bison Wealth’s AbbVie ABBV Stock Holding History

Bison Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-500
Closed -$54K – 357
2021
Q3 		$54K Buy
+500
New +$57.1K 0.02% 308

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Koshinski Asset Management
Koshinski Asset Management Decatur, Illinois $1.88B AUM 29.07% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Bison Wealth's ABBV Position: Q4 2024 in Review

Bison Wealth reduced its AbbVie (ABBV) stake by 44% in Q4 2024, selling an estimated $1.56M and leaving 10,881 shares worth $1.93M. The position accounts for 0.43% of the portfolio, ranked #53.

Bison Wealth first reported a position in ABBV in Q4 2014 and has held it in 41 quarters since. The position peaked at $3.82M in Q3 2024. 3,745 funds tracked by Wall St. Rank hold ABBV as of Q4 2024.

  • Bison Wealth held 10,881 shares of AbbVie worth $1.93M as of Q4 2024.
  • Bison Wealth sold 8,460 AbbVie shares in Q4 2024, an estimated $1.56M.
  • AbbVie made up 0.43% of Bison Wealth's portfolio in Q4 2024, its #53 holding.
  • Bison Wealth first reported a position in AbbVie in Q4 2014 and has held it in 41 quarters since.
  • Bison Wealth's AbbVie position peaked at $3.82M in Q3 2024.
  • 3,745 funds tracked by Wall St. Rank held AbbVie as of Q4 2024.

Based on Bison Wealth's 13F filing for Q4 2024, filed 14 Feb 2025.